US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 2.950
  • -0.090-2.96%
Close Jun 7 16:00 ET
  • 2.950
  • 0.0000.00%
Post 16:02 ET
89.01MMarket Cap-942P/E (TTM)

Relmada Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-36.87%83.61M
-35.06%96.32M
-35.06%96.32M
-42.29%106.27M
-44.08%118.53M
-39.98%132.44M
-30.01%148.32M
-30.01%148.32M
109.06%184.15M
94.33%211.96M
-Cash and cash equivalents
-95.38%1.34M
-24.17%4.09M
-24.17%4.09M
-84.25%6.7M
-61.17%14.47M
-35.70%28.89M
-87.86%5.4M
-87.86%5.4M
271.41%42.52M
697.99%37.26M
-Short-term investments
-20.54%82.28M
-35.47%92.23M
-35.47%92.23M
-29.70%99.57M
-40.43%104.06M
-41.07%103.55M
-14.65%142.93M
-14.65%142.93M
84.80%141.63M
67.33%174.69M
Receivables
----
--0
--0
--0
--0
--0
493.25%512.43K
493.25%512.43K
--0
-49.02%42.23K
-Other receivables
----
----
----
----
----
----
493.25%512.43K
493.25%512.43K
----
-49.02%42.23K
Prepaid assets
-75.65%752.33K
-70.63%1.19M
-70.63%1.19M
-4.05%2.83M
-0.26%3.47M
-69.05%3.09M
-64.30%4.04M
-64.30%4.04M
14.55%2.95M
136.66%3.48M
Other current assets
----
----
----
-5.13%37
----
----
----
----
-99.97%39
233.29%256.24K
Total current assets
-37.75%84.37M
-36.21%97.51M
-36.21%97.51M
-41.69%109.1M
-43.45%122M
-39.97%135.53M
-31.54%152.87M
-31.54%152.87M
105.87%187.11M
94.88%215.74M
Non current assets
Other non current assets
23.66%43.13K
23.66%43.13K
23.66%43.13K
196.46%47.72K
-1.84%34.59K
23.26%34.88K
23.26%34.88K
23.26%34.88K
-35.62%16.1K
40.95%35.24K
Total non current assets
23.66%43.13K
23.66%43.13K
23.66%43.13K
196.46%47.72K
-1.84%34.59K
23.26%34.88K
23.26%34.88K
23.26%34.88K
-65.95%16.1K
-49.00%35.24K
Total assets
-37.74%84.41M
-36.20%97.55M
-36.20%97.55M
-41.67%109.15M
-43.44%122.04M
-39.96%135.57M
-31.53%152.91M
-31.53%152.91M
105.78%187.12M
94.79%215.77M
Liabilities
Current liabilities
Payables
17.35%5.19M
-33.37%3.51M
-33.37%3.51M
-72.60%2.86M
-35.63%4.85M
-58.56%4.42M
-52.99%5.26M
-52.99%5.26M
-17.96%10.43M
-27.89%7.54M
-accounts payable
17.35%5.19M
-33.37%3.51M
-33.37%3.51M
-72.60%2.86M
-35.63%4.85M
-58.56%4.42M
-52.99%5.26M
-52.99%5.26M
-17.96%10.43M
-27.89%7.54M
Current accrued expenses
21.00%6.87M
-9.81%6.06M
-9.81%6.06M
-51.37%4.46M
-44.83%5.85M
31.48%5.68M
150.80%6.71M
150.80%6.71M
96.25%9.17M
277.18%10.6M
Other current liabilities
----
-121.95%-9
-121.95%-9
-383.33%-34
----
----
78.26%41
78.26%41
200.00%12
-252.38%-32
Current liabilities
22.43%12.36M
-2.20%12.19M
-2.20%12.19M
-59.46%8.42M
-43.44%10.7M
-34.47%10.1M
-17.21%12.47M
-17.21%12.47M
13.86%20.78M
35.96%18.92M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
22.43%12.36M
-2.20%12.19M
-2.20%12.19M
-59.46%8.42M
-43.44%10.7M
-34.47%10.1M
-17.21%12.47M
-17.21%12.47M
13.86%20.78M
35.96%18.92M
Shareholders'equity
Share capital
0.25%30.17K
0.00%30.1K
0.00%30.1K
5.09%30.1K
0.25%30.1K
2.37%30.1K
8.50%30.1K
8.50%30.1K
63.65%28.64K
71.88%30.03K
-common stock
0.25%30.17K
0.00%30.1K
0.00%30.1K
5.09%30.1K
0.25%30.1K
2.37%30.1K
8.50%30.1K
8.50%30.1K
63.65%28.64K
71.88%30.03K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-19.31%-582.73M
-21.38%-560.9M
-21.38%-560.9M
-26.30%-535.74M
-33.53%-513.74M
-41.65%-488.43M
-51.48%-462.11M
-51.48%-462.11M
-56.70%-424.17M
-68.69%-384.75M
Paid-in capital
6.66%654.75M
7.26%646.23M
7.26%646.23M
7.78%636.43M
7.47%625.04M
10.57%613.87M
17.38%602.52M
17.38%602.52M
71.97%590.48M
78.99%581.57M
Total stockholders'equity
-42.58%72.05M
-39.22%85.36M
-39.22%85.36M
-39.45%100.73M
-43.44%111.34M
-40.37%125.47M
-32.57%140.44M
-32.57%140.44M
128.85%166.34M
103.25%196.85M
Total equity
-42.58%72.05M
-39.22%85.36M
-39.22%85.36M
-39.45%100.73M
-43.44%111.34M
-40.37%125.47M
-32.57%140.44M
-32.57%140.44M
128.85%166.34M
103.25%196.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -36.87%83.61M-35.06%96.32M-35.06%96.32M-42.29%106.27M-44.08%118.53M-39.98%132.44M-30.01%148.32M-30.01%148.32M109.06%184.15M94.33%211.96M
-Cash and cash equivalents -95.38%1.34M-24.17%4.09M-24.17%4.09M-84.25%6.7M-61.17%14.47M-35.70%28.89M-87.86%5.4M-87.86%5.4M271.41%42.52M697.99%37.26M
-Short-term investments -20.54%82.28M-35.47%92.23M-35.47%92.23M-29.70%99.57M-40.43%104.06M-41.07%103.55M-14.65%142.93M-14.65%142.93M84.80%141.63M67.33%174.69M
Receivables ------0--0--0--0--0493.25%512.43K493.25%512.43K--0-49.02%42.23K
-Other receivables ------------------------493.25%512.43K493.25%512.43K-----49.02%42.23K
Prepaid assets -75.65%752.33K-70.63%1.19M-70.63%1.19M-4.05%2.83M-0.26%3.47M-69.05%3.09M-64.30%4.04M-64.30%4.04M14.55%2.95M136.66%3.48M
Other current assets -------------5.13%37-----------------99.97%39233.29%256.24K
Total current assets -37.75%84.37M-36.21%97.51M-36.21%97.51M-41.69%109.1M-43.45%122M-39.97%135.53M-31.54%152.87M-31.54%152.87M105.87%187.11M94.88%215.74M
Non current assets
Other non current assets 23.66%43.13K23.66%43.13K23.66%43.13K196.46%47.72K-1.84%34.59K23.26%34.88K23.26%34.88K23.26%34.88K-35.62%16.1K40.95%35.24K
Total non current assets 23.66%43.13K23.66%43.13K23.66%43.13K196.46%47.72K-1.84%34.59K23.26%34.88K23.26%34.88K23.26%34.88K-65.95%16.1K-49.00%35.24K
Total assets -37.74%84.41M-36.20%97.55M-36.20%97.55M-41.67%109.15M-43.44%122.04M-39.96%135.57M-31.53%152.91M-31.53%152.91M105.78%187.12M94.79%215.77M
Liabilities
Current liabilities
Payables 17.35%5.19M-33.37%3.51M-33.37%3.51M-72.60%2.86M-35.63%4.85M-58.56%4.42M-52.99%5.26M-52.99%5.26M-17.96%10.43M-27.89%7.54M
-accounts payable 17.35%5.19M-33.37%3.51M-33.37%3.51M-72.60%2.86M-35.63%4.85M-58.56%4.42M-52.99%5.26M-52.99%5.26M-17.96%10.43M-27.89%7.54M
Current accrued expenses 21.00%6.87M-9.81%6.06M-9.81%6.06M-51.37%4.46M-44.83%5.85M31.48%5.68M150.80%6.71M150.80%6.71M96.25%9.17M277.18%10.6M
Other current liabilities -----121.95%-9-121.95%-9-383.33%-34--------78.26%4178.26%41200.00%12-252.38%-32
Current liabilities 22.43%12.36M-2.20%12.19M-2.20%12.19M-59.46%8.42M-43.44%10.7M-34.47%10.1M-17.21%12.47M-17.21%12.47M13.86%20.78M35.96%18.92M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 22.43%12.36M-2.20%12.19M-2.20%12.19M-59.46%8.42M-43.44%10.7M-34.47%10.1M-17.21%12.47M-17.21%12.47M13.86%20.78M35.96%18.92M
Shareholders'equity
Share capital 0.25%30.17K0.00%30.1K0.00%30.1K5.09%30.1K0.25%30.1K2.37%30.1K8.50%30.1K8.50%30.1K63.65%28.64K71.88%30.03K
-common stock 0.25%30.17K0.00%30.1K0.00%30.1K5.09%30.1K0.25%30.1K2.37%30.1K8.50%30.1K8.50%30.1K63.65%28.64K71.88%30.03K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -19.31%-582.73M-21.38%-560.9M-21.38%-560.9M-26.30%-535.74M-33.53%-513.74M-41.65%-488.43M-51.48%-462.11M-51.48%-462.11M-56.70%-424.17M-68.69%-384.75M
Paid-in capital 6.66%654.75M7.26%646.23M7.26%646.23M7.78%636.43M7.47%625.04M10.57%613.87M17.38%602.52M17.38%602.52M71.97%590.48M78.99%581.57M
Total stockholders'equity -42.58%72.05M-39.22%85.36M-39.22%85.36M-39.45%100.73M-43.44%111.34M-40.37%125.47M-32.57%140.44M-32.57%140.44M128.85%166.34M103.25%196.85M
Total equity -42.58%72.05M-39.22%85.36M-39.22%85.36M-39.45%100.73M-43.44%111.34M-40.37%125.47M-32.57%140.44M-32.57%140.44M128.85%166.34M103.25%196.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg